| P50 | author | Clifton D. Fuller | Q40409885 |
| | Ethan B Ludmir | Q50285839 |
| | Dario Pasalic | Q57085827 |
| | Mara B Antonoff | Q61194092 |
| | Adam S Garden | Q90650674 |
| | William H Morrison | Q90650679 |
| P2093 | author name string | Chad Tang | |
| | Yi Lu | |
| | James W Welsh | |
| | Joe Y Chang | |
| | Zhongxing Liao | |
| | David I Rosenthal | |
| | Pamela K Allen | |
| | Jack Phan | |
| | Jeremy J Erasmus | |
| | Quynh-Nhu Nguyen | |
| | Nicolette Taku | |
| | Sonia L Betancourt-Cuellar | |
| P2860 | cites work | Platinum-based chemotherapy plus cetuximab in head and neck cancer | Q33381094 |
| | Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis | Q33604263 |
| | Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know | Q37774807 |
| | The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support | Q38273676 |
| | Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned | Q38290655 |
| | Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. | Q38367916 |
| | Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Q38409259 |
| | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | Q38790915 |
| | Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. | Q38864596 |
| | Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study | Q39675331 |
| | Pathologists' staging of multiple foci of lung cancer: poor concordance in absence of dramatic histologic or molecular differences | Q41073520 |
| | Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial | Q49039293 |
| | Distant metastases in head and neck cancer | Q49084069 |
| | Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. | Q53363634 |
| | Multiple primary tumours: challenges and approaches, a review. | Q54942556 |
| | Oligometastases revisited | Q56773912 |
| | Pulmonary Metastasectomy for Head and Neck Cancers | Q63548376 |
| | Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy | Q69015014 |
| | Metastatic patterns in squamous cell cancer of the head and neck | Q69414531 |
| | Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas | Q84450141 |
| | Second primary lung malignancy in head and neck cancer patients | Q85046637 |
| | Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study | Q90224620 |
| | Epidemiologic Signatures in Cancer | Q90438334 |
| | Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals | Q91541904 |
| | Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes | Q91787159 |
| | Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study | Q91852299 |
| | The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Appl | Q92273044 |
| | Integration of radiotherapy and immunotherapy for treatment of oligometastases | Q92306383 |
| | Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial | Q93080682 |
| P921 | main subject | head and neck cancer | Q1783924 |
| | head and neck carcinoma | Q18554836 |
| | neck cancer | Q18966654 |
| P577 | publication date | 2020-03-04 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer | |